Abscisic Acid (b)

CAS No. 21293-29-8

Abscisic Acid (b)( Abscisic acid )

Catalog No. M17431 CAS No. 21293-29-8

Abscisic Acid is a plant hormone, which is involved in many plant developmental processes, modulates ion homeostasis and metabolism, and inhibits germination and seedling growth.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 50 In Stock
10MG 80 In Stock
25MG 143 In Stock
50MG 245 In Stock
100MG 356 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Abscisic Acid (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    Abscisic Acid is a plant hormone, which is involved in many plant developmental processes, modulates ion homeostasis and metabolism, and inhibits germination and seedling growth.
  • Description
    Abscisic acid is a plant hormone and growth regulator.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Diet-induced obesity (DIO) mice at 4 weeks of ageDosage:0.125?μg/kg Administration:Orally; daily; for 12 weeks Result:Improved glycemic control in a diet-induced model of obesity
  • Synonyms
    Abscisic acid
  • Pathway
    Tyrosine Kinase
  • Target
    Bcr-Abl
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    21293-29-8
  • Formula Weight
    264.32
  • Molecular Formula
    C15H20O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (378.33 mM)
  • SMILES
    CC(\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C)=C\C(O)=O
  • Chemical Name
    (2Z,4E)-5-((S)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-enyl)-3-methylpenta-2,4-dienoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Addicott FT, Lyon JL,et al.Science. 1968 Mar 29;159(3822):1493.
molnova catalog
related products
  • Dasatinib monohydrat...

    Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML).

  • PP1

    PP1 is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.

  • ZM 306416

    ZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, but also found to inhibit EGFR with IC50 of <10 nM.